Literature DB >> 7247350

Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives.

D L Oblack, W L Hewitt, W J Martin.   

Abstract

The in vitro antifungal activities of two N-aminoacyl derivatives of amphotericin B methyl ester (AME) were compared by tube dilution with those of amphotericin B and AME, using 60 isolates representing 10 yeast species. A total of 70% of the strains were inhibited by concentrations of the N-aminoacyl AME derivatives that were within a twofold dilution of the amphotericin B or AME minimum inhibitory concentration. The fungicidal activity of the N-aminoacyl AME derivatives was 3- to 16-fold lower than that of amphotericin B for 8 of 10 species. A considerable spectrum of antifungal activity was observed for N-aminoacyl derivatives of AME, which represents a new class of water-soluble polyene antibiotics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247350      PMCID: PMC181365          DOI: 10.1128/AAC.19.1.106

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester.

Authors:  W R Howarth; R P Tewari; M Solotorovsky
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

Review 2.  Chemotherapy of systemic mycoses (second of two parts).

Authors:  J E Bennett
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

3.  A new therapeutic approach to Candida infections. A preliminary report.

Authors:  G Medoff; W E Dismukes; R H Meade; J M Moses
Journal:  Arch Intern Med       Date:  1972-08

4.  Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy.

Authors:  D J Drutz; A Spickard; D E Rogers; M G Koenig
Journal:  Am J Med       Date:  1968-09       Impact factor: 4.965

5.  Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth.

Authors:  E F Gale; A M Johnson; D Kerridge; T Y Koh
Journal:  J Gen Microbiol       Date:  1975-03

6.  Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.

Authors:  D P Bonner; R P Tewari; M Solotorovsky; W Mechlinski; C P Schaffner
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

7.  Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity.

Authors:  R M Lawrence; P D Hoeprich
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

8.  Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.

Authors:  H H Gadebusch; F Pansy; C Klepner; R Schwind
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

9.  Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats, and dogs.

Authors:  G R Keim; P L Sibley; Y H Yoon; J S Kulesza; I H Zaidi; M M Miller; J W Poutsiaka
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Comparative susceptibility of Candida albicans to amphotericin B and amphotericin B methyl ester.

Authors:  R M Bannatyne; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

View more
  6 in total

1.  In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.

Authors:  G S Kobayashi; J R Little; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

2.  Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.

Authors:  R M Parmegiani; D Loebenberg; B Antonacci; T Yarosh-Tomaine; R Scupp; J J Wright; P J Chiu; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

3.  Effect of nystatin, amphotericin B and amphotericin B methyl ester on Saccharomyces cerevisiae with different lipid composition.

Authors:  M A de Resende; F Alterthum
Journal:  Mycopathologia       Date:  1990-12       Impact factor: 2.574

Review 4.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

5.  Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.

Authors:  J R Perfect; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.

Authors:  L Saint-Julien; V Joly; M Seman; C Carbon; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.